Payments to Acquire Property, Plant, and Equipment of Fusion Pharmaceuticals Inc. from 31 Dec 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Fusion Pharmaceuticals Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2019 to 31 Mar 2024.
  • Fusion Pharmaceuticals Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $1,334,000, a 9.1% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $3,890,000, a 82% increase from 2022.
  • Fusion Pharmaceuticals Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $2,142,000, a 44% increase from 2021.
  • Fusion Pharmaceuticals Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $1,491,000, a 33% increase from 2020.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Fusion Pharmaceuticals Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,334,000 +$111,000 +9.1% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q1 2023 $1,223,000 +$628,000 +106% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $595,000 +$11,000 +1.9% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1
Q1 2021 $584,000 +$370,000 +173% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $214,000 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021 2021 Q1

Fusion Pharmaceuticals Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $3,890,000 +$1,748,000 +82% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2024 2023 FY
2022 $2,142,000 +$651,000 +44% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024 2023 FY
2021 $1,491,000 +$368,000 +33% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $1,123,000 +$667,000 +146% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $456,000 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.